Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion type Assertion NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_head.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion description "[Individuals who carried polymorphisms for GSTT1 null and/or high activity microsomal epoxide hydrolase (mEH 113YY+139HR or 113YY+139RR or 113YH+139RR) and/or low activity NAD(P)H:quinone oxidoreductase 1 (NQO1 187PS/SS) were 1.65, 2.49 and 13 times more likely to have MM (P(trend)=0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_provenance.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion evidence source_evidence_literature NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_provenance.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion SIO_000772 16949155 NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_provenance.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion wasDerivedFrom befree-20150227 NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_provenance.
- NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_assertion wasGeneratedBy ECO_0000203 NP328725.RARRZfgWMDZKstFUcVgh5NKSUjfIUc-Ekrp6vfyWPYplI130_provenance.